Brito, Jeffrey T.

HRN: 22-98-23  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/11/2023
CEFUROXIME 1.5GM (VIAL)
06/11/2023
06/17/2023
IV
1.5G
Q8
Obstructive Jaundice Sec To Cholelithiasis With Choledocholithiases; T/c Cholangitis
Waiting Final Action 
06/11/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/11/2023
06/17/2023
IV
500mg
Q8
Obstructive Jaundice Sec To Cholelithiasis With Choledocholithiases T/c Cholangitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: